|
��չ����
|
|
| ������Ϣ | |
 |
Supporting info |
|
PDFȫ�� |
|
[HTMLȫ��] |
|
����� |
| �����뷴�� | |
|
�������ù����� |
|
���� |
|
Email Alert |
|
���·��� |
|
���������Ϣ |
| ���Ĺؼ���������� | |
|
��ͺ |
|
���� |
| ��������������� | |
|
���� |
|
��ѧ�� |
|
��ɭ |
| PubMed | |
|
Article by |
|
Article by |
|
Article by |
��ͺ������ѧ�о���չ
����, ��ѧ��, ��ɭ
����ҽ�ƴ�ѧƤ�����о���, �Ϸ�230022
��ͺ��һ�����ԡ������ԡ�ë��������Ƥ����,���������Ѿ��γɺͷ�չ�˶������Ʒ���,�����ڱ�������������,�Ҹ������Ʒ�����������̲�����ȱ��������Ч,��˶���Щ���Ʒ�������Ч���۱Ƚ����ѡ����ж���Щ���Ʒ����ڸ��ְ�ͺ�����е�Ӧ�á����û��ơ���Ӧ֤�������۽���������
[2] Madani S, Shapiro J. Alopecia areata update. J Am Acad Dermatol,2000, 42(4):549-566.
[3] Marty E, Maria K. Why steroids may not always work in alopecia areata:elevated unomlupied glucocorticoid receptors and decreased levels of thioredoxin. Dermatol Therapy,2001,14(4):317-321.
[4] Wiseman MC, Shapiro J, MacDonald N, et al. Predictive model for immunotherapy of alopecia areata with diphencyprone. Arch Dermatol, 2001, 137(8):1063-1068.
[5] Charuwichitratana S, Wattanakrai P, Tanrattanakorn S. Randomized double-blind placebo-controlled trial in the treatment of alopecia areata with 0.25% desoximetasone cream. Arch Dermatol, 2000,136(10):1276-1277.
[6] Alabdulkareem AS, Abahussein AA, Okoro A. Severe alopecia areata treated with systemic corticosteroids. Int J Dermatol, 1998, 37 (8):622-624.
[7] Price VH. Treatment of hair loss. N Engl J Med, 1999, 341 (13):964-973.
[8] Happle R. Antigenic competition as a therapeutic concept for alopecia areata. Arch Dermatol Res, 1980, 267(1):109-114.
[9] Cotellessa C, Peris K, Caracciolo E, et al. The use of topical diphenylcyclopropenone for the treatment of extensive alopecia areata. J Am Acad Dermatol, 2001,44(1):73-76.
[10] Micali G, Cicero RL, Nasca MR, et al. Treatment of alopecia areata with squaric acid dibutylester. Int J Dermatol, 1996, 35 (1):52-56.
[11] van der Steen P, Happle R. Dyschromia in confetti'as a side effect of topical immunotherapy with diphenylcyclopropenone. Arch Dermatol,1992, 128(4):518-520.
[12] Taylor CR, Hawk JL. PUVA treatment of alopecia areata partialis, totalis and universalis:audit of 10 years'experience at St John's Institute of Dermatology. Br J Dermatol, 1995, 133(6):914-918.
[13] Behrens-Williams SC, Leiter U, Schiener R,et al. The PUVA-turban as a new option of applying a dilute psoralen solution selectively to the scalp of patients with alopecia areata. J Am Acad Dermatol, 2001,44(2):248-252.
[14] Shapiro J, Lui H, Tron V, et al. Systemic cyclosporine and low-dose prednisone in the treatment of chronic severe alopecia areata:a clinical and immunopathologic evaluation. J Am Acad Dermatol, 1997, 36(1):114-117.
[15] Macdonald Hull S. Double blind placebo controlled study of dapsone in the treatment of alopecia areata. In:RVA van Neste D, ed. Hair research for the next millenium. vol 1. Amsterdam:Elsevier Science,1996. 275-277.
[16] van der Velden EM, Drost BH, Ijsselmuiden OE, et al. Dermatography as a new treatment for alopecia areata of the eyebrows. Int J Dermatol, 1998, 37(8):617-621.
[17] Goldman GD. Eyebrow transplantation. Dermatol Surg, 2001, 27(4):352-354.
[18] Sawaya ME, Shapiro J. Androgenetic alope cia. New approved and unapproved treatments. Dermatol Clin, 2000, 18(1):47-61.
[19] Shapiro J, Price VH. Hair regrowth. Therapeutic agents. Dermatol Clin, 1998, 16(2):341-356.